University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Items where Author is "Parker, C"

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 4.

Article

Pandha, HS, Protheroe, A, Wylie, J, Parker, C, Chambers, J, Bell, S and Munzert, G (2008) An open label phase II trial of BI 2536, a novel Plk1 inhibitor, in patients with metastatic hormone refractory prostate cancer (HRPC) JOURNAL OF CLINICAL ONCOLOGY, 26 (15).

Mcnair, HA, Hansen, VN, Parker, CC, Evans, PM, Norman, A, Miles, E, Harris, EJ, Del-Acroix, L, Smith, E, Keane, R, Khoo, VS, Thompson, AC and Dearnaley, DP (2008) A comparison of the use of bony anatomy and internal markers for offline verification and an evaluation of the potential benefit of online and offline verification protocols for prostate radiotherapy INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 71 (1). pp. 41-50.

Gilbert, DC and Parker, C (2005) Docetaxel for the treatment of prostate cancer. Future Oncol, 1 (3). pp. 307-314.

Conference or Workshop Item

Michael, A, Plowright, L, Boxall, A, Bhatt, A, Di Palma, S, Parker, C and Pandha, H Evaluation of EN2 as a urine-based biomarker for prostate cancer. In: ASCO, 2010-06-03 - 2010-06-07, Chicago USA.

This list was generated on Fri Nov 24 09:32:15 2017 UTC.

Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800